News > Aarti Drugs to buyback shares worth Rs 60 crore

Aarti Drugs to buyback shares worth Rs 60 crore

The company's board approved a buyback of up to 6.65 lakh shares with a face value of Rs 10 each, representing up to 0.72% of the total paid-up equity shares. The company has fixed the buyback price at Rs 900 per share, a 60% premium to the current market levels. The company has set Sept 5 as the record date for the share buyback through the 'tender offer' route, which means that the buyback price will remain fixed and will not change.